Profil
John Harlan is the founder of CisThera, Inc. He previously worked as a Director at ZymoGenetics, Inc. and Cytel Corp.
Additionally, he held a Principal position at the University of Washington from 1989 to 2004.
Anciens postes connus de John Harlan
Sociétés | Poste | Fin |
---|---|---|
University of Washington
University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | Corporate Officer/Principal | 01/01/2004 |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Directeur/Membre du Conseil | - |
Cytel Corp. | Directeur/Membre du Conseil | - |
CisThera, Inc.
CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 3 |
---|---|
CisThera, Inc.
CisThera, Inc. Pharmaceuticals: MajorHealth Technology CisThera, Inc. operates as a biopharmaceutical company. It develops therapeutics to treat cancer, autoimmune diseases, as well as chronic kidney and liver diseases. The company was founded by John Harlan and is headquartered in Kirkland, WA. | Health Technology |
Cytel Corp. | |
ZymoGenetics, Inc.
ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA. | Health Technology |